AmpliPhi’s Bacteriophage Manufacturing Facility Receives cGMP Certification

/in

First cGMP-certified manufacturing facility commissioned to manufacture bacteriophage products for human use. Link here. San Diego and Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, June 3, 2014 – AmpliPhi BioSciences Corporation. (OTCQB: APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that its production facility in Ljubljana, Slovenia, was […]

Read more

Rex Bionics – First Patient Treated in RAPPER II Clinical Trial

/in ,

1 June 2015 Rex Bionics Plc (AIM: RBX), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, is pleased to announce that the first patient has been successfully treated in its RAPPER II (“Robot-Assisted PhysiotheraPy Exercises with REX”) clinical trial. Link here. A 37 year-old male with a spinal cord injury at level T3, […]

Read more